105 related articles for article (PubMed ID: 12860278)
21. Induction and expression of betaig-h3 in pancreatic cancer cells.
Schneider D; Kleeff J; Berberat PO; Zhu Z; Korc M; Friess H; Büchler MW
Biochim Biophys Acta; 2002 Oct; 1588(1):1-6. PubMed ID: 12379307
[TBL] [Abstract][Full Text] [Related]
22. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome.
Okano H; Shinohara H; Miyamoto A; Takaori K; Tanigawa N
Clin Cancer Res; 2004 Oct; 10(20):6938-45. PubMed ID: 15501972
[TBL] [Abstract][Full Text] [Related]
23. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
24. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T
Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625
[TBL] [Abstract][Full Text] [Related]
25. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice.
Xu X; Brodie SG; Yang X; Im YH; Parks WT; Chen L; Zhou YX; Weinstein M; Kim SJ; Deng CX
Oncogene; 2000 Apr; 19(15):1868-74. PubMed ID: 10773876
[TBL] [Abstract][Full Text] [Related]
26. Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.
Villanueva A; García C; Paules AB; Vicente M; Megías M; Reyes G; de Villalonga P; Agell N; Lluís F; Bachs O; Capellá G
Oncogene; 1998 Oct; 17(15):1969-78. PubMed ID: 9788440
[TBL] [Abstract][Full Text] [Related]
27. [Detection of the expression of Smad4, transforming growth factor beta(1) and beta receptor II proteins in paraffin-embedded human pancreatic cancer tissues].
Gu L; Chen J; Liu T; Li L; Lu Z; Luo Y
Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):439-42. PubMed ID: 11866987
[TBL] [Abstract][Full Text] [Related]
28. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
29. c-Src and hydrogen peroxide mediate transforming growth factor-beta1-induced smooth muscle cell-gene expression in 10T1/2 cells.
Sato M; Kawai-Kowase K; Sato H; Oyama Y; Kanai H; Ohyama Y; Suga T; Maeno T; Aoki Y; Tamura J; Sakamoto H; Nagai R; Kurabayashi M
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):341-7. PubMed ID: 15591224
[TBL] [Abstract][Full Text] [Related]
30. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
31. Decrease of Smad4 gene expression in patients with essential thrombocythaemia may cause an escape from suppression of megakaryopoiesis by transforming growth factor-beta1.
Kuroda H; Matsunaga T; Terui T; Tanaka I; Takimoto R; Fujikawa K; Takayama T; Kato J; Hirayama Y; Sakamaki S; Kohda K; Niitsu Y
Br J Haematol; 2004 Jan; 124(2):211-20. PubMed ID: 14687032
[TBL] [Abstract][Full Text] [Related]
32. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells.
Kim SG; Jong HS; Kim TY; Lee JW; Kim NK; Hong SH; Bang YJ
Mol Biol Cell; 2004 Feb; 15(2):420-34. PubMed ID: 14595120
[TBL] [Abstract][Full Text] [Related]
34. Smad4 expression in gastric adenoma and adenocarcinoma: frequent loss of expression in diffuse type of gastric adenocarcinoma.
Kim JY; Park DY; Kim GH; Choi KU; Lee CH; Huh GY; Sol MY; Song GA; Jeon TY; Kim DH; Sim MS
Histol Histopathol; 2005 Apr; 20(2):543-9. PubMed ID: 15736060
[TBL] [Abstract][Full Text] [Related]
35. Smad4 is required for the normal organization of the cartilage growth plate.
Zhang J; Tan X; Li W; Wang Y; Wang J; Cheng X; Yang X
Dev Biol; 2005 Aug; 284(2):311-22. PubMed ID: 16023633
[TBL] [Abstract][Full Text] [Related]
36. Expression of transforming-growth-factor (TGF)-beta receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-beta1.
Piek E; Westermark U; Kastemar M; Heldin CH; van Zoelen EJ; Nistér M; Ten Dijke P
Int J Cancer; 1999 Mar; 80(5):756-63. PubMed ID: 10048979
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
[TBL] [Abstract][Full Text] [Related]
38. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
39. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
[TBL] [Abstract][Full Text] [Related]
40. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity.
Hummer BT; Bartlett C; Henry E; Weissman BE
J Cell Physiol; 2003 Mar; 194(3):289-302. PubMed ID: 12548549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
